PER-059-02已完成未知
MULTICENTRIC, DOUBLE-BLIND, FACTORIAL STUDY CONTROLLED WITH PLACEBO AND RANDOMIZED TO EVALUATE EFFICACY AND SAFETY IN THE ALTERATION OF LIPIDS OF THE EZETIMIBE / SIMVASTATIN MIXED TABLET IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2002年9月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a. Men or women> 18 and <80 years of age.
- •b. People willing to make a regimen of Therapeutic Changes of
- •Lifestyle (TLC) of the NCEP or a similar diet of cholesterol reduction during the course of the study.
排除标准
- •a. Weight <50% of the ideal body weight according to the Weight and Height Tables
- •Metropolitans of 1983 (Appendix 2) or weighing <100 pounds (45 kg).
- •b. Hypersensitivity to HMG.-CoA reductase inhibitors.
- •c. Patients who already receive lipid reduction therapy in which the
- •suspension of therapy for the course of the study would be inappropriate to
- •the investigator´s judgment.
- •d. Alcohol consumption> 14 drinks per week.
- •e. Pregnant women or breastfeeding
研究者
相似试验
已完成
不适用
Montelukast Asthmatic Smoker Study-J459 Asthma, unspecifiedAsthma, unspecifiedJ459PER-008-06MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A DOUBLE-BLIND, RANDOMIZED, MULTI-CENTRAL STUDY OF 3 PERIODS, CROSSED TO EVALUATE THE EFFECTS OF A SINGLE DOSE OF MONTELUKAST COMPARED TO THE PLACEBO AND SALMETEROL IN BRONCHOCONSTRICTION INDUCED BY EXERCISE-J45J45PER-059-05MERCK & CO.INC.,
已完成
不适用
MULTICENTRIC, RANDOMIZED, DOUBLE-BLIND STUDY, IN PARALLEL GROUPS, WITH ACTIVE CONTROL, OF 24 WEEKS OF DURATION, TO EVALUATE THE EFFICACY OF THE COMBINATION VALSARTAN / HYDROCHLOROTHYAZIDE VERSUS AMLODIPINE ON THE SYSTOLIC ARTERIAL PRESSURE IN PATIENTS WITH MODERATE HYPERTENSION WITH RISK FACTORS AND / OR CARDIOVASCULAR CONCOMYANT DISEASE-I10 Essential (primary) hypertensionEssential (primary) hypertensionI10PER-010-03OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE CLINICAL EFFECTS OF MONTELUKAST INTRAVENOUS WITH PLACEBO IN PEDIATRIC PATIENTS (BETWEEN 6 AND 14 YEARS OLD) WHO SUFFER FROM ACUTE ASTHMA-J459 Asthma, unspecifiedAsthma, unspecifiedJ459PER-028-05MERCK & CO.INC.,
已完成
不适用
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE CLINICAL EFFECTS OF MONTELUKAST INTRAVENOUS WITH PLACEBO IN PATIENTS WITH ACUTE ASTHMAPER-034-04MERCK & CO.INC.,